Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 145.25
-3.75 (-2.52%)
Aug 12, 2026, 10:24 AM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 126.47 million as of August 12, 2026. Its market cap has increased by 8.77% in one year.
Market Cap
126.47M
Enterprise Value
120.28M
Revenue
38.44M
Ranking
n/a
PE Ratio
1,303.84
Stock Price
145.25
ChartMarket Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 126.47M, an increase of 90.32%. That is a compound annual growth rate of 9.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 126.47M | 16.36% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.51B |
| GSK plc | 78.56B |
| Haleon | 32.54B |
| Smith & Nephew | 9.36B |
| Tristel | 196.74M |
| Scancell Holdings | 114.56M |
| EKF Diagnostics Holdings | 111.93M |
| AOTI, Inc. | 103.70M |